Kazia Therapeutics Limited
KZIA
$3.82
-$0.11-2.80%
NASDAQ
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -17.58M | -13.97M | -10.41M | -12.01M | -13.76M |
| Total Depreciation and Amortization | 1.23M | 1.23M | 1.24M | 1.24M | 1.26M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.50M | 1.22M | -1.07M | -849.80K | -609.80K |
| Change in Net Operating Assets | 6.58M | 4.19M | 1.81M | 2.35M | 2.92M |
| Cash from Operations | -6.28M | -7.33M | -8.43M | -9.26M | -10.20M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 776.00K | 776.30K | 776.60K | 388.30K | -- |
| Total Debt Repaid | -371.00K | -371.40K | -371.80K | -185.90K | -- |
| Issuance of Common Stock | 5.96M | 9.07M | 12.19M | 12.78M | 13.37M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -376.60K | -549.10K | -721.60K | -561.20K | -400.80K |
| Cash from Financing | 3.92M | 5.89M | 7.92M | 8.29M | 8.74M |
| Foreign Exchange rate Adjustments | 8.30K | -900.00 | -9.40K | 17.00K | 43.40K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.35M | -1.44M | -521.80K | -951.60K | -1.42M |